Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Gene silencing of glypican-3 in clear cell carcinoma of the ovary renders it more sensitive to the apoptotic agent paclitaxel in vitro and in vivo
Cancer Science, 11/02/09
Umezu T et al. – The results indicate that increased GPC3 expression in a clear cell carcinoma cell line may play a protective role against apoptosis, and so the downregulation of GPC3 may be a potential target to increase sensitivity to paclitaxel–induced apoptosis in clear cell carcinoma.
Related Articles
Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer
Breast Cancer Research and Treatment, 11/12/09
Relevance Score: 70%
Hepatic Stellate Cell-Specific Gene Silencing Induced by an Artificial MicroRNA for Antifibrosis In Vitro
Digestive Diseases and Sciences, 11/10/09
Relevance Score: 66%
Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer
Cancer, 11/06/09
Relevance Score: 65%
RNAi-mediated silencing of ezrin gene reverses malignant behavior of human gastric cancer cell line SGC-7901
Journal of Digestive Diseases, 10/29/09
Relevance Score: 65%
Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells
British Journal of Cancer, 10/16/09
Relevance Score: 65%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Identification of novel ER-alpha target genes in breast cancer cells: Gene- and cell-selective co-regulator recruitment at target promoters determines the response to 17beta-estradiol and tamoxifen
Molecular and Cellular Endocrinology, 11/24/09
Isolation and Characterization of Spheroid Cells from Human Malignant Melanoma Cell Line WM-266-4
Tumor Biology, 11/24/09
Targeting Vascular Endothelial Growth Factor in Renal Cell Carcinoma
Tumor Biology, 11/24/09
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Co-Expression of p53 and Bcl-2 Proteins in Human Papillomavirus-Induced Premalignant Lesions of the Uterine Cervix: Correlation with Progression to Malignancy
Tumor Biology, 11/24/09
Phase II clinical trial of ixabepilone in patients with recurrent or persistent platinum- and taxane-resistant ovarian or primary peritoneal cancer: A Gynecologic Oncology Group Study
Journal of Clinical Oncology, 11/24/09
Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges
Journal of Oncology, 11/24/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


